title: Preventive evolutionary medicine of cancers.
abstract: Evolutionary theory predicts that once an individual reaches an age of sufficiently low Darwinian fitness, (s)he will have reduced chances of keeping cancerous lesions in check. While we clearly need to better understand the emergence of precursor states and early malignancies as well as their mitigation by the microenvironment and tissue architecture, we argue that lifestyle changes and preventive therapies based in an evolutionary framework, applied to identified high-risk populations before incipient neoplasms become clinically detectable and chemoresistant lineages emerge, are currently the most reliable way to control or eliminate early tumours. Specifically, the relatively low levels of (epi)genetic heterogeneity characteristic of many if not most incipient lesions will mean a relatively limited set of possible adaptive traits and associated costs compared to more advanced cancers, and thus a more complete and predictable understanding of treatment options and outcomes. We propose a conceptual model for preventive treatments and discuss the many associated challenges.
authors: ISEM, UMR5554 CNRS/UM2/IRD, Université Montpellier 2 Montpellier, France ; The Santa Fe Institute Santa Fe, NM, USA ; CREEC, Université Montpellier 2 Montpellier, France.
authors: Michael E
authors: ME
authors: Hochberg
authors: Frédéric
authors: F
authors: Thomas
authors: Eric
authors: E
authors: Assenat
authors: Urszula
authors: U
authors: Hibner
keywords: cancer; chemotherapy; evolution; evolutionary cell biology; lifestyle; microenvironment; preventative evolutionary medicine; prevention
references: Cancer Res. 2012 May 1;72(9):2350-61
references: 22396490
references: J Immunol. 2011 Feb 1;186(3):1325-31
references: 21248270
references: Nat Rev Cancer. 2007 Feb;7(2):139-47
references: 17218951
references: Science. 2009 Jun 26;324(5935):1679-82
references: 19556501
references: Nature. 2010 Oct 28;467(7319):1114-7
references: 20981102
references: Nat Rev Cancer. 2011 Nov 10;11(12):879-85
references: 22071977
references: Cancer Res. 2010 Feb 15;70(4):1700-10
references: 20145144
references: Eur J Cancer Prev. 2012 May;21(3):222-6
references: 22273850
references: Curr Cancer Drug Targets. 2012 Feb;12(2):124-31
references: 22229245
references: Nat Rev Cancer. 2010 Feb;10(2):87-101
references: 20094044
references: Nat Rev Cancer. 2005 Aug;5(8):655-62
references: 16056261
references: Proc Natl Acad Sci U S A. 2011 Jun 28;108 Suppl 2:10871-7
references: 21690376
references: Trends Genet. 1993 Apr;9(4):138-41
references: 8516849
references: Mol Oncol. 2012 Apr;6(2):155-76
references: 22440008
references: Cell. 2011 Mar 4;144(5):646-74
references: 21376230
references: Nat Cell Biol. 2007 Sep;9(9):1016-24
references: 17762893
references: J Natl Cancer Inst. 2010 May 5;102(9):605-13
references: 20413742
references: Cell. 2011 Jun 24;145(7):1023-35
references: 21703447
references: J Clin Oncol. 2008 Aug 1;26(22):3785-90
references: 18591545
references: PLoS Biol. 2012;10(4):e1001296
references: 22509130
references: Lancet. 2012 Apr 28;379(9826):1602-12
references: 22440946
references: Nat Rev Cancer. 2011 Jun;11(6):450-7
references: 21593786
references: Lancet. 2010 Jul 24;376(9737):235-44
references: 20609467
references: N Engl J Med. 2012 Mar 8;366(10):883-892
references: 22397650
references: Lancet Oncol. 2010 Oct;11(10):942-9
references: 20864406
references: Curr Opin Urol. 2012 May;22(3):203-9
references: 22472510
references: J Natl Cancer Inst. 2011 Jan 19;103(2):117-28
references: 21228314
references: Cancer Res. 2009 Oct 1;69(19):7499-502
references: 19752088
references: PLoS Biol. 2008 Dec 23;6(12):e4
references: 19222305
references: Cancer Prev Res (Phila). 2011 Jul;4(7):1135-44
references: 21490131
references: Nature. 2004 Feb 26;427(6977):787
references: 14985739
references: Oncogene. 1987;2(1):3-7
references: 3325884
references: Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1558-68
references: 15466970
references: Genet Med. 2010 May;12(5):245-59
references: 20216074
references: Genetics. 1946 May;31:269-90
references: 20985721
references: J Hepatol. 2012 Nov;57(5):1021-8
references: 22750466
references: Gastroenterology. 2010 Jun;138(6):2140-50
references: 20420951
references: Lancet Oncol. 2012 Jun;13(6):607-15
references: 22575588
references: Cancer Res. 2004 May 15;64(10):3414-27
references: 15150093
references: Nature. 1998 Dec 17;396(6712):643-9
references: 9872311
references: Nat Med. 2011 Mar;17(3):320-9
references: 21383745
references: Nat Rev Cancer. 2008 Jan;8(1):56-61
references: 18059462
references: Nat Rev Cancer. 2011 Apr;11(4):237-8
references: 21548400
references: Open Med. 2007;1(3):e184-90
references: 21673951
references: J Urol. 2012 Aug;188(2):624-31
references: 22704445
references: Front Pharmacol. 2011 Aug 25;2:49
references: 21904528
references: Genes Dev. 2012 May 1;26(9):877-90
references: 22549953
references: Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9714-9
references: 15980154
references: Mol Oncol. 2012 Apr;6(2):109-10
references: 22507633
references: Curr Opin Genet Dev. 2012 Feb;22(1):21-7
references: 22321988
references: J Exp Med. 2011 Apr 11;208(4):653-61
references: 21464223
references: Nature. 2012 Mar 28;483(7391):570-5
references: 22460902
references: Nat Rev Cancer. 2011 Jun 24;11(7):467-80
references: 21701511
references: N Engl J Med. 2012 Sep 6;367(10):895-903
references: 22931259
references: Nat Rev Cancer. 2012 Jun 14;12(7):487-93
references: 22695393
references: Annu Rev Immunol. 2004;22:329-60
references: 15032581
references: Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4283-8
references: 18337506
references: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50
references: 20876136
references: Cancer Res. 2011 Jun 1;71(11):3739-44
references: 21610109
references: J Evol Biol. 2003 May;16(3):378-87
references: 14635838
references: Int J Cancer. 2004 Oct 10;111(6):944-50
references: 15300808
references: Vaccine. 2008 Jul 18;26 Suppl 3:C4-7
references: 18773527
references: Semin Radiat Oncol. 2010 Oct;20(4):274-81
references: 20832020
references: Science. 2012 Feb 24;335(6071):936-41
references: 22363001
references: Trends Biochem Sci. 1994 Apr;19(4):172-6
references: 8016868
references: Trends Ecol Evol. 2005 Oct;20(10):545-52
references: 16701433
references: Semin Cancer Biol. 2008 Oct;18(5):330-7
references: 18455429
references: Nat Rev Immunol. 2003 Aug;3(8):630-41
references: 12974478
references: Nature. 2012 Jan 18;481(7381):306-13
references: 22258609